Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SNWV Stock Summary
Top 10 Correlated ETFs
SNWV
In the News
SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results
EDEN PRAIRIE, MN, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results.
SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results
EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financial results.
SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update
EDEN PRAIRIE, MN, May 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, May 12, 2023, at 9:00AM (EDT) to discuss a financial update and recent strategic initiatives.
SANUWAVE Will Host a Live Conference Call and Webcast April 3, 2023 at 9:00 AM to Provide a Financial and Business Update
Eden Prairie, MN, March 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Monday, April 3, 2023, at 9:00AM (EDT) to discuss a financial update and recent strategic initiatives.
SANUWAVE(R) to Present Thursday October 13th at the Microcap Rodeo Presents The Windy City Roundup 2022
EDEN PRAIRIE, MN / ACCESSWIRE / October 11, 2022 / SANUWAVE Health, Inc. (OTC PINK:SNWV), a leading provider of next-generation wound care products has been invited to present at the Microcap Rodeo presents The Windy City Roundup 2022 conference, which is being held live Wednesday and Thursday October 12th - 13th, 2022. SANUWAVE will present a live investor presentation on Thursday, October 13, 2022, at 10:30 AM (CT).
SANUWAVE Health Reports Second Quarter 2022 Financial Results & Will Host Live Conference Call With Business Update
Eden Prairie, MN, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, reported financial results for their second quarter ending June 30, 2022, with the SEC on Friday, August 12, 2022. The Company will host a live conference call on Tuesday, August 16, 2022, at 12:30 (EDT) to provide a business update (Dial-in information below).
SANUWAVE Health to Present at the Emerging Growth Conference on March 2, 2022
SANUWAVE invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference
SANUWAVE Health to Host Conference Call and Provide Business Update
SANUWAVE will hold a conference call on Wednesday, March 2, 2022 at 9:00 am ET
SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Business Update Call (Transcript)
SANUWAVE Health, Inc. (SNWV) CEO Kevin Richardson on Business Update Call (Transcript)
SANUWAVE Health to Host Conference Call and Provide Business Update
SANUWAVE will hold a conference call on Wednesday, January 19, 2022, at 9am ET to discuss its recent business activity
SNWV Financial details
SNWV Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 | |
Net income per share | -0.06 | -0.09 | -0.05 | -0.02 | -0.03 | |
Operating cash flow per share | -0.03 | -0.03 | -0.01 | -0.03 | -0.01 | |
Free cash flow per share | -0.03 | -0.03 | -0.01 | -0.03 | -0.01 | |
Cash per share | 0.01 | 0.01 | 0 | 0 | 0 | |
Book value per share | -0.05 | -0.04 | -0.08 | -0.07 | -0.05 | |
Tangible book value per share | -0.05 | -0.07 | -0.1 | -0.1 | -0.06 | |
Share holders equity per share | -0.05 | -0.04 | -0.08 | -0.07 | -0.05 | |
Interest debt per share | 0.04 | 0.05 | 0.06 | 0.1 | 0.06 | |
Market cap | 32.49M | 69.95M | 88.12M | 12.53M | 10.32M | |
Enterprise value | 37.65M | 85.1M | 113.7M | 52.48M | 40.47M | |
P/E ratio | -2.65 | -2.05 | -3.23 | -1.22 | -0.4 | |
Price to sales ratio | 31.58 | 17.24 | 6.77 | 0.75 | 0.51 | |
POCF ratio | -5.07 | -5.5 | -13.75 | -0.73 | -2.27 | |
PFCF ratio | -5.03 | -5.48 | -12.7 | -0.78 | -2.27 | |
P/B Ratio | -3.23 | -5.1 | -2.26 | -0.31 | -0.24 | |
PTB ratio | -3.23 | -5.1 | -2.26 | -0.31 | -0.24 | |
EV to sales | 36.6 | 20.97 | 8.74 | 3.13 | 1.98 | |
Enterprise value over EBITDA | -4.32 | -5.19 | -6.9 | -4.59 | 82.92 | |
EV to operating cash flow | -5.87 | -6.69 | -17.74 | -3.06 | -8.92 | |
EV to free cash flow | -5.82 | -6.66 | -16.39 | -3.25 | -8.92 | |
Earnings yield | -0.38 | -0.49 | -0.31 | -0.82 | -2.5 | |
Free cash flow yield | -0.2 | -0.18 | -0.08 | -1.29 | -0.44 | |
Debt to equity | -0.69 | -1.28 | -0.67 | -1 | -0.73 | |
Debt to assets | 2.05 | 0.76 | 1.41 | 2.07 | 1.4 | |
Net debt to EBITDA | -0.59 | -0.92 | -1.55 | -3.49 | 61.78 | |
Current ratio | 0.2 | 0.22 | 0.08 | 0.11 | 0.15 | |
Interest coverage | -4.79 | -7.09 | -1.99 | -0.63 | -0.03 | |
Income quality | 0.61 | 0.41 | 0.24 | 1.67 | 0.18 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 6.26 | 3.38 | 0.9 | 0.75 | 0.43 | |
Research and developement to revenue | 1.15 | 0.31 | 0.08 | 0.03 | 0.03 | |
Intangibles to total assets | 0 | 0.6 | 0.7 | 0.62 | 0.05 | |
Capex to operating cash flow | 0.01 | 0 | 0.08 | -0.06 | 0 | |
Capex to revenue | -0.05 | -0.01 | -0.04 | 0.06 | 0 | |
Capex to depreciation | -0.76 | -0.05 | -0.43 | 1.07 | 0 | |
Stock based compensation to revenue | 0.32 | 0.01 | 0.22 | -0.03 | -0.03 | |
Graham number | 0.26 | 0.27 | 0.3 | 0.18 | 0.2 | |
ROIC | 4.33 | -4.22 | 1.14 | -16.77 | 0.05 | |
Return on tangible assets | -3.63 | -3.7 | -4.94 | -1.38 | -1.21 | |
Graham Net | -0.06 | -0.08 | -0.11 | -0.1 | -0.08 | |
Working capital | -9.91M | -28.25M | -51.86M | -53.57M | -54.97M | |
Tangible asset value | -10.06M | -27.52M | -52.06M | -53.41M | -44.34M | |
Net current asset value | -10.94M | -28.82M | -53.18M | -54.26M | -55.81M | |
Invested capital | -0.69 | -1.28 | -0.67 | -1 | -0.73 | |
Average receivables | 155.77K | 1.22M | 2.39M | 3.22M | 3.67M | |
Average payables | 1.52M | 2.95M | 6.05M | 6.02M | 5.05M | |
Average inventory | 450.39K | 1.75M | 2M | 954K | 1.91M | |
Days sales outstanding | 26.8 | 211.89 | 67.75 | 87.84 | 59.3 | |
Days payables outstanding | 974.88 | 1.4K | 559.58 | 370.82 | 306.81 | |
Days of inventory on hand | 367.73 | 928.61 | 76.13 | 73.15 | 158.7 | |
Receivables turnover | 13.62 | 1.72 | 5.39 | 4.16 | 6.16 | |
Payables turnover | 0.37 | 0.26 | 0.65 | 0.98 | 1.19 | |
Inventory turnover | 0.99 | 0.39 | 4.79 | 4.99 | 2.3 | |
ROE | 1.22 | 2.48 | 0.7 | 0.25 | 0.6 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net income per share | -0.01 | -0.05 | -0.01 | -0.03 | 0.02 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | -0.05 | -0.09 | -0.1 | -0.07 | -0.04 | |
Tangible book value per share | -0.06 | -0.11 | -0.13 | -0.09 | -0.05 | |
Share holders equity per share | -0.05 | -0.09 | -0.1 | -0.07 | -0.04 | |
Interest debt per share | 0.05 | 0.08 | 0.09 | 0.04 | 0.03 | |
Market cap | 19.88M | 24.15M | 13.22M | 18.84M | 14.83M | |
Enterprise value | 59.83M | 63.99M | 58.27M | 55.66M | 44.97M | |
P/E ratio | -0.61 | -0.22 | -0.46 | -0.2 | 0.2 | |
Price to sales ratio | 3.61 | 6.4 | 2.83 | 3.8 | 2.12 | |
POCF ratio | -4.98 | -65.1 | -15.66 | -9.25 | -11.54 | |
PFCF ratio | -6.69 | -62.09 | -13.29 | -9.25 | -13.29 | |
P/B Ratio | -0.48 | -0.45 | -0.22 | -0.29 | -0.34 | |
PTB ratio | -0.48 | -0.45 | -0.22 | -0.29 | -0.34 | |
EV to sales | 10.88 | 16.95 | 12.46 | 11.24 | 6.43 | |
Enterprise value over EBITDA | -21.8 | -36.65 | 51.71 | -354.52 | 34.95 | |
EV to operating cash flow | -14.98 | -172.49 | -69.04 | -27.31 | -35 | |
EV to free cash flow | -20.14 | -164.5 | -58.56 | -27.31 | -40.3 | |
Earnings yield | -0.41 | -1.15 | -0.55 | -1.26 | 1.23 | |
Free cash flow yield | -0.15 | -0.02 | -0.08 | -0.11 | -0.08 | |
Debt to equity | -1 | -0.74 | -0.75 | -0.57 | -0.73 | |
Debt to assets | 2.07 | 2.28 | 2.36 | 1.86 | 1.4 | |
Net debt to EBITDA | -14.55 | -22.82 | 39.98 | -234.51 | 23.42 | |
Current ratio | 0.11 | 0.06 | 0.08 | 0.09 | 0.15 | |
Interest coverage | -0.69 | -0.46 | 0.21 | 0.12 | 0.33 | |
Income quality | 0.49 | 0.03 | 0.12 | 0.09 | -0.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.74 | 0.73 | 0.26 | 0.54 | 0.29 | |
Research and developement to revenue | 0.01 | 0.03 | 0.03 | 0.03 | 0.02 | |
Intangibles to total assets | 0.62 | 0.7 | 0.63 | 0.58 | 0.05 | |
Capex to operating cash flow | -0.26 | 0.05 | 0.18 | 0 | -0.13 | |
Capex to revenue | 0.19 | 0 | -0.03 | 0 | 0.02 | |
Capex to depreciation | 3.77 | -0.07 | -0.59 | 0 | 0.68 | |
Stock based compensation to revenue | -0.09 | 0 | 0.05 | 0 | -0.03 | |
Graham number | 0.1 | 0.32 | 0.17 | 0.21 | 0.12 | |
ROIC | -5.65 | 0.31 | -0.1 | 0.01 | -0.09 | |
Return on tangible assets | -1.09 | -5.29 | -1.02 | -2.8 | 0.86 | |
Graham Net | -0.06 | -0.12 | -0.13 | -0.09 | -0.05 | |
Working capital | -53.57M | -66.13M | -73.18M | -78.04M | -54.97M | |
Tangible asset value | -53.41M | -66.01M | -72.88M | -77.82M | -44.34M | |
Net current asset value | -54.26M | -66.77M | -73.93M | -78.9M | -55.81M | |
Invested capital | -1 | -0.74 | -0.75 | -0.57 | -0.73 | |
Average receivables | 3.22M | 3.5M | 2.89M | 3.02M | 3.27M | |
Average payables | 4.73M | 4.83M | 5.06M | 4.74M | 5.16M | |
Average inventory | 1.14M | 969.5K | 985.5K | 1.31M | 2.33M | |
Days sales outstanding | 65.93 | 70.78 | 54.25 | 58.71 | 42.65 | |
Days payables outstanding | 227.46 | 375.4 | 363.82 | 294.67 | 218.68 | |
Days of inventory on hand | 44.87 | 76.38 | 67.39 | 109.19 | 113.11 | |
Receivables turnover | 1.37 | 1.27 | 1.66 | 1.53 | 2.11 | |
Payables turnover | 0.4 | 0.24 | 0.25 | 0.31 | 0.41 | |
Inventory turnover | 2.01 | 1.18 | 1.34 | 0.82 | 0.8 | |
ROE | 0.2 | 0.52 | 0.12 | 0.36 | -0.42 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SNWV Frequently Asked Questions
What is SANUWAVE Health, Inc. stock symbol ?
SANUWAVE Health, Inc. is a US stock , located in Suwanee of Ga and trading under the symbol SNWV
What is SANUWAVE Health, Inc. stock quote today ?
SANUWAVE Health, Inc. stock price is $0.02156 today.
Is SANUWAVE Health, Inc. stock public?
Yes, SANUWAVE Health, Inc. is a publicly traded company.